ArticleBMC medical research methodology2025

Addressing challenges with Matching-Adjusted Indirect Comparisons to demonstrate the comparative effectiveness of entrectinib in metastatic ROS-1 positive Non-Small Cell Lung Cancer.

Cyril Esnault et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.